Figure 3From: Is the thymidine labeling index a good prognostic marker in breast cancer?Among patients with stage II disease, patients with low TLI were found to have improved 5-year overall survival rates compared with patients with high TLI, but it did not reach the statistical significance (p = 0.07).Back to article page